San-ei Sucrochemical

What San-ei Sucrochemical does

San-ei Sucrochemical Co., Ltd. (サンエイ糖化株式会社) is a Japanese integrated saccharification manufacturer headquartered in Chita City, Aichi Prefecture, with origins tracing to Tokai Sugar Industry, established in 1958. The company produces crystalline glucose, dextrin/powder syrup, isomerized liquid sugar, oligosaccharic acid (maltobionic acid), and related saccharification ingredients from corn starch using proprietary enzymatic hydrolysis and crystallization processes. It pioneered the world's first direct cooking method for anhydrous crystalline glucose in 1960 and achieved Japan's first domestic production of Japanese Pharmacopoeia Glucose in 1966. The company commands an estimated ~50%+ domestic market share in crystalline glucose overall, with particularly dominant positions in medical infusion (~85%) and dialysis (~90%) applications, and operates one of Japan's few large-scale lactic acid bacteria cultivation operations as a secondary business line.

The company operates on a B2B direct sales model through three regional sales offices (Tokyo, Osaka, Nagoya) serving pharmaceutical manufacturers, food manufacturers, and industrial customers. Revenue streams consist of saccharified product manufacturing/sales (primarily one-time sales contracts), contract lactic acid bacteria cultivation services (professional services), and sales of the proprietary San-ei Lacto starter culture line. Pricing is non-public and negotiated on a quote/contract basis with enterprise customers. Distribution leverages a nationwide warehouse network from Hokkaido to Kyushu utilizing marine and rail transport for efficiency. Production is concentrated at the Chita headquarters factory, Second Factory (dextrin operations, completed 2014), and Bio Factory (lactic acid bacteria, expanded 2016).

Since December 2020, San-ei Sucrochemical has operated as a wholly-owned subsidiary of Showa Sangyo Co., Ltd. (a Tokyo Stock Exchange-listed diversified grain solutions conglomerate), enabling access to the parent group's sales network and complementary supply capabilities. The company has invested in R&D expansion, completing a new Innovation Center in November 2025 and launching the Biosyslab joint venture with Fujita Health University in June 2025 to commercialize maltobionic acid research for bone and gut health applications. Disclosed revenue is ¥19.3 billion for FY2026 (March 2026), with 253 employees as of June 2026.

Name

San-ei Sucrochemical

Legal name

San-ei Sucrochemical Co., Ltd. (サンエイ糖化株式会社)

Website

https://sanei-toka.co.jp

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

251–500 employees

Short description

San-ei Sucrochemical is a Japanese integrated saccharification manufacturer producing crystalline glucose, dextrin, and maltobionic acid for pharmaceutical, food, and industrial B2B customers, operating as a wholly-owned subsidiary of Showa Sangyo Group.

Ownership category

akta.pro rank

Product category

Saccharified sugar ingredients (industrial starch-derived sugar products)

NAICS

Sugar and Confectionery Product Manufacturing (3113), Starch and Vegetable Fats and Oils Manufacturing (31122)

SIC

Sugar & Confectionery Products (2060), Food And Kindred Products (2000)

akta.pro primary industry

Glucose Syrups & Dextrose (Corn/Wheat/Tapioca Glucose, Dextrose Monohydrate) (AFAJAAAD)

akta.pro secondary industries

Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts) (CRADAOAI), Liquid Sugar & Invert Sugar (Liquid Sucrose, Invert Syrups) (AFAJAAAC)

Keywords

• Sugar manufacturing
• Pharmaceutical ingredients
• Food saccharification
• Lactic acid bacteria
• Starch processing

Headquarters

HQ city

Chita

HQ country

Japan

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Revenue model

1. 糖化製品製造販売: とうもろこし等のでん粉を原料とした一貫製造による結晶ぶどう糖、デキストリン、粉飴、異性化液糖、オリゴ糖酸（マルトビオン酸含有）等の製造販売。食品・医療・工業向けに製品销售。B2B形式。
2. 乳酸菌等有用菌の受託培養: 顧客保有の乳酸菌・ビフィズス菌等の有用微生物の大量培養・粉末化・スターター化のを受託製造。30年以上の実績を持つ。試作～スケールアップ～本製造まで対応。
3. 乳酸菌スターター販売: 有用乳酸菌を純粋培養して濃縮凍結した業務用乳酸菌スターター「サンエイラクト」シリーズの銷售。味噌・醤油向け・漬物向けなど用途별製品を展開。

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

San-ei Sucrochemical is an integrated saccharification manufacturer that produces crystalline glucose, isomerized liquid sugar, dextrin, powder syrup, oligosaccharic acid (maltobionic acid), and related starch-derived sugar products from corn and other starches for pharmaceutical, food, and industrial customers. The company also operates a contract manufacturing business for lactic acid bacteria, bifidobacteria, and other useful microorganisms, providing large-scale cultivation, powderization, and starter culture products. All production is supplied B2B to enterprise customers across Japan.

Differentiator

Problem solved

Functional benefit

Brands

• San-ei Lacto (サンエイラクト): Lactic acid bacteria starter products for commercial use, including miso brewing and pickle production
• Sour Oligo (サワーオリゴ)
• Sour Oligo C (サワーオリゴC)
• Glu Final (グル・ファイナル)
• Nipodex (ニポデックス)

Products and services

• Crystalline glucose (結晶ぶどう糖) High-purity crystalline glucose manufactured from starch via saccharification, supplied as Japanese Pharmacopoeia-grade and food/industrial grades for pharmaceutical manufacturers (IV solutions, dialysis, injections, oral medicines, drink agents), food producers, and industrial users including fermentation media and brewing.
• Isomerized liquid sugar and liquid glucose (異性化液糖・液状ぶどう糖) Liquid sugar products made by partially isomerizing liquid glucose to fructose to enhance sweetness, with glucose and fructose as main components, supplied to food manufacturers for confectionery, beverages, dairy products, seasonings, and processed foods.
• Dextrin and powder syrup (デキストリン・粉飴) Starch-derived powder products manufactured by enzymatic hydrolysis of starch, supplied as powder-base and bulking ingredients widely used in powdered food products including seasonings, processed foods, and pharmaceuticals.
• Oligosaccharic acid / Maltobionic acid (オリゴ糖酸 / マルトビオン酸) Acidic saccharide produced by reacting starch syrup with saccharification enzymes, with proprietary Sour Oligo and Sour Oligo C product variants (including calcium-containing powder), supplied as functional food ingredients with research-supported benefits for bone density maintenance, mineral absorption promotion, and bowel regularity.
• Contract cultivation of lactic acid bacteria and useful microorganisms (乳酸菌等有用菌の受託培養) OEM contract manufacturing service providing large-scale cultivation, powderization (freeze-drying and spray-drying), and starter production for customer-supplied lactic acid bacteria, bifidobacteria, and other useful microorganisms, supporting anaerobic and aerobic cultivation, with 30+ years of track record from trial through commercial-scale production.
• San-ei Lacto lactic acid bacteria starter series (サンエイラクト) Commercial lactic acid bacteria starter products sold under the San-ei Lacto brand, including application-specific starters for miso brewing, soy sauce production, and pickle manufacturing, plus concentrated-and-lyophilized industrial-use lactic acid bacteria starters.
• Glu Final full sugar glucose product line (グル・ファイナル) Full-sugar glucose product line manufactured using a spray whole-sugar crystallization method, including the Glu Final and Glu Final 2000 variants, supplied to food and pharmaceutical manufacturers and certified Kosher.
• Nipodex dextrin product series (ニポデックスス) Dextrin product series including powder dextrin NSD variants, supplied as powder-base and bulking ingredients for food, pharmaceutical, and industrial customers, with Halal and Kosher certifications.

Quantifiable outcome

• 国内結晶ぶどう糖シェア 約50%以上
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• 藤田医科大学coreStrategic or Co-development Partner · 12 June 20252024年2月に共同研究を開始。マルトビオン酸の腸内細菌に対する作用メカニズムの解明及び骨粗鬆症の新補完治療への応用研究を実施。2025年6月には藤田医科大学公認"バイオシスラボ"として共同展開も開始し、骨と腸をつなぐ新健康習慣"肠活"事业に协り组んでいる。糖と発酵をキーワードにしたオープンイノベーションの重要パートナー。
• 株式会社バイオシスラボcoreStrategic or Co-development Partner · 12 June 2025藤田医科大学公認"肠活ベンチャーバイオシスラボ"が始動。サンエイ糖化の"マルトビオン酸で挑む、骨と腸をつなぐ新・健康習慣"と藤田医科大学的腸活研究の研究成果を活かし、商品开发・的事业化を推進する新会社。サンエイ糖化の素材供应・研究成果と-bioSysLabの事業化ノウハウの連携。
• 昭和産業株式会社coreOthers · 1 December 20202020年12月、全株式を昭和産業に转让。昭和産業グループ"穀物ソリューション・カンパニー"の一員となる。グループの技術力和生産基盤を活用した更なる成長・発展目指す。昭和産業のRD&E部門との連携強化、研究開発、商品開発を推進している。グループ内での相互補完による安定供給体制も構築。

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Roquette: Global leader in starch-based polyols, sorbitol, and pharmaceutical excipients with Japanese operations — competing with San-ei in pharmaceutical-grade glucose and specialty polyols.
• Ingredion: Major global corn-derived sweetener and starch manufacturer with Japan presence — broad incumbent in markets adjacent to San-ei's saccharification products.
• Archer Daniels Midland Japan: Global agriculture processor with Japanese presence in sweeteners and starch products — broader incumbent whose Japanese operations overlap San-ei's B2B saccharification customers.
• Showa Sangyo: Parent company and TSE-listed diversified grain solutions conglomerate with broader portfolio including flour, oil, and feed. Comparable on saccharification but also operates adjacent large-scale grain processing lines.
• Cargill Japan: Global agribusiness with Japanese sugar and starch operations — competing with San-ei in food-grade and industrial sweetener markets.

Direct peers

• Nippon Corn Starch: Major Japanese corn starch and starch derivative manufacturer supplying downstream saccharification users — upstream supplier/competitor overlap with San-ei's corn-based saccharification business.
• Towa Chemical Industry: Japanese producer of sugar alcohols, glucose, and specialty saccharification products for food and pharmaceutical applications — direct competitor in Japan's specialty sweetener market.
• San-ei Sucrochemical (San'ei Shoji Foods): Japanese food ingredient manufacturer producing starch-derived sugars and adhesives — competing in similar Japanese B2B ingredient markets.
• Nihon Shokuhin Kako: Japanese starch and saccharification manufacturer producing glucose, maltose, dextrin, and isomerized sugar — directly comparable product portfolio and B2B customer base to San-ei Sucrochemical.
• Matsutani Chemical Industry: Leading Japanese manufacturer of dextrin, polyols, and starch-derived functional ingredients serving food, pharmaceutical, and industrial customers — overlapping product lines and customer segments with San-ei.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about San-ei Sucrochemical